- Home
- IFBD vs ADXN Comparison
IFBD vs ADXN Comparison
Compare IFBD & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IFBD | ADXN |
|---|---|---|
| Founded | 2001 | 2002 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.6M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IFBD | ADXN |
|---|---|---|
| Price | $1.01 | $6.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 163.4K | 3.7K |
| Earning Date | 05-01-2023 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $5.41 |
| 52 Week High | $2.18 | $12.05 |
Technical Indicators
Market Signals| Indicator | IFBD | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 50.74 | 50.45 |
| Support Level | $0.88 | $5.78 |
| Resistance Level | $1.13 | $7.37 |
| Average True Range (ATR) | 0.22 | 0.38 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 12.82 | 46.81 |
Price Performance
Historical ComparisonAbout IFBD Infobird Co. Ltd
Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.